The Maharashtra Authority for Advance Ruling (AAR) has determined that the cancer prognostic and diagnostic services provided by Epigeneres Biotech Private Limited do not qualify for exemption from ...

Pursuant to Regulation 30 and 33 of the SEBI(LODR) regulations, 2015, as amended from time to time, we enclosed herewith the unaudited standalone and consolidated financial statement for the second ...

As with the infamous Y2K computer bug, tariffs are shaping up largely as an irrelevance for US-exposed ASX biotechs. Remember that one? It was meant to bring mayhem to corporate Australia and ...

The resignation of Peter Marks, long-time director of the US Food and Drug Administration’s (FDA) centre responsible for assessing vaccines and other biological products, has exacerbated growing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Thursday, April 3rd, IPO Scoop reports. The company will be issuing 2,700,000 shares at $7.50-$8.50 per share.